Novo Nordisk Research Centre Oxford (NNRCO) is an innovative target discovery and translational research institute with a focus on identifying new therapeutic opportunities for patients with type 2 diabetes and cardiometabolic diseases.
NNRCO is located in the Innovation Building on the Old Road Campus, Oxford. Building on a longstanding relationship, Novo Nordisk and University of Oxford have formed the landmark strategic alliance anchored at NNRCO, which has been in operation since mid-2017.
With its close proximity to academic centers of excellence within Oxford, London and Cambridge, NNRCO embraces collaboration opportunities in this unique and innovative ecosystem. These collaborations aim to advance discovery and translational research, which ultimately will yield innovative therapies that will make a difference to the lives of patients.
NNRCO employs advanced bioinformatics, state-of-the-art discovery
screening technologies and human centric systems to dissect
pathophysiology and identify novel drug targets. It takes full
advantage of academic-industrial collaborations, human genetics and
big data to conduct world-class discovery and translational
NNRCO News & Events
On September 12th, 2018, NNRCO officially inaugurated its
new research facilities within the Innovation Building.
Bill Haynes leads NNRCO. Bill is a physician-scientist with more than 20 years’ experience in academic-industry translational research across cardio-metabolic diseases. Bill trained in medicine and research in the UK and was a professor of endocrinology and cardiovascular diseases at the University of Iowa. Following this, Bill worked in discovery research and translational medicine at Novartis and AstraZeneca and has led multiple high-profile collaborations with academic institutions. Bill joined NNRCO in December 2018.
Job opportunities at NNCRO
We are recruiting for various exciting roles at NNRCO, view our current vacancies.
Learn more about R&D across Novo Nordisk
This page is intended for members of the UK public
UK/WB/0917/0041 Date of Preparation September 2017